Did you know lung cancer is the leading cause of cancer death in the U.S.? According to the U.S. Preventive Services Task Force, the 5-year survival rate is only about 28.1%. In an effort to improve these odds, federal health officials have made lung cancer screening accessible to more people by expanding eligibility criteria.
Lung cancer is the leading cause of cancer death in the United States, claiming roughly as many lives each year as prostate, colon and breast cancer combined. But while we do have a way to screen for lung cancer—and catching lung cancer early greatly increases the patient’s chances—only a small percentage are taking advantage.
Do you know how dense your breasts are? If you’re a woman age 40 or older, you should. Breast density is an extremely important factor to consider when screening for breast cancer and can influence decisions you make when scheduling your annual mammogram.
In 2025, roughly 313,780 men in the US will learn they have prostate cancer and 35,770 will die from it. Since 2014, that rate has only been increasing. But a new targeted therapy called Pluvicto is changing the game.
In the late 1990s, colorectal cancer was the fourth leading cause of cancer death for men and women in the United States under age 50. Today, it is the leading cause of cancer death for men under 50 and second for women.